Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $120 at Oppenheimer on Solid Q2 Beat

July 29, 2015 6:28 AM
Oppenheimer analyst Wendy Lam reiterated an Outperform rating and boosted her price target on Gilead Sciences (NASDAQ: GILD) to $120.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles